FDA Investigator Tiffani D Wilson

Tiffani D Wilson has inspections in 10 countries as of 16 May 2023. Tiffani D Wilson has collaborated with a combinined 3770 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
25
Last Inspection Date:
16 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Mexico, United States of America, Germany, United Kingdom of Great Britain and Northern Ireland, Sweden, Switzerland, Denmark, France, Iceland, Netherlands
Co-Investigator(s):
Akbar J Zaidi, Alice S Tsao, Alicia M Mozzachio, Amanda E Lewin, PhD, Amy M Cramer, Anastasia I Offordile, Anastasia M Shields, Andrew J Barrowcliff, Anita R Michael, Ankur C Patel, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Anthony A Charity, Anthony N Onianwa, Arindam Dasgupta, PhD, Azza Talaat, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Barbara M Frazier, Bijoy Panicker, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Byungja E Marciante, Christina K Theodorou, Chryste D Best, Constance Y Fears, Craig D Zagata, Cynthia A Palmer, Cynthia J Lee, MS, Cynthia L Rakestraw, Daniel J Deciero, Daniel J Grabicki, Daniel J Mechenbier, Daniel J Min, Darla J Christopher, David A Oluwo, David M Beltran, Deborah J Parris, Denise M Digiulio, Dennis Cantellops Paite, Diane T Bargo, Diane T O'brien, Donald L Lech, Douglas A Campbell, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Mark J Seaton, PhD, Emest F Bizjak, Erica L Nicoll, Farhana Khan, Frederick Razzaghi, Gajendiran Mahadevan, PhD, Gayle S Lawson, George Pyramides, Gerald B Seaborn, Jr, Gianine E Tompkins, Gwyn G Dickinson, Hala L Selby, Hala Lj Whetstone, Hasan A Irier, PhD, Helen B Ricalde, Heriberto Negron Rivera, Ivis Lnegron Torres, James A Lane, James M Mason, James M Odonnell, James Norman, James R Birkenstamm, James W Plucinski, Jean Blackston Hill, Jeffrey A Sommers, Jennifer L Gustavus, Jessica S Estriplet, Joanne Hajoway, Joanne M Hajoway, Joel D Hustedt, Joey V Quitania, John A Podsadowski, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose M Cayuela, Jose R Hernandez, Joseph R Hatcher, Joshua P Wireman, Julianne C Mccullough, Junho Pak, Karen A Briggs, Karen S Anthony, Karen Takahashi, Kendra L Brooks, Kenneth M Gordon, Kenneth Nieves, Kent C Faul, Ko U Min, Kristina J Donohue, Kristy A Zielny, Lance M De Souza, MBA, LCDR Chad N Thompson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, LCDR William H Bender, Liatte Kreuger, PharmD, Linda M Hoover, Lisa L Flores, Lisa M Bellows, Lisa M Feola, Lisa Relloos, Lisa Shie, Lisa Shin, Lloyd D Payne, Lori A Holmquist, Lori A Holquist, Lori B Wikstrom, Lori S Lawless, Lori Wikstrom, Lourdes Valentin Aponte, LTJG Bradley E Benasutti, Lucas B Leake, Luis A Carrion, Luis A Dasta, Lynette P Salisbury, Marcellinus D Dordunoo, Marcus F Yambot, Margaret Faulkner, Maria A Bienkowski, Maria A Reed, Maria A Ruttell, Marie Bbuen Bigornia, Marisol Faberlle, Mark E Parmon, Mary R Kirker, Matthew M Henciak, Matthew R Noonan, Meena Bansal Gupta, PhD, Melba Trivera Clavell, Melissa J Garcia, Merideth K Rose, Michael L Casner, Michael R Klapal, Michele Gottshall, Michele L Obert, Michele M Falchek, Monica E Murie, Monika Borkowska, Mra Davism, Mra Mcculloughj, Nicholas A Violand, Nyungja E Marciente, Patrick C Klotzbuecher, Paul L Bellamy, Prabhu P Raju, Qin Xu, Rachel C Harrington, Rafael Nevarez Nieves, Raquel Gonzalez Rivera, Rebecca Rodriguez, Regina T Brown, Richard H Penta, Robert J Martin, Roy R Rinc, Ruben C Ayala, PharmD, Russell J Glapion, Saied A Asbagh, Saleem A Akhtar, Sam Pepe, Sandra A Hughes, Shirley J Berryman, Simone E Pitts, Sneha S Patel, Stephen J Koniers, Suzanne M Healy, Suzanne M Muchene, Suzanne N Vallez, Suzanne Vallez, Taichun Qin, PhD, Tamil Arasu, PhD, Tammy L Chavis, Tammy M Phillips, Tara G Bizjak, Tarun D Mehta, Theresa Kirkham (NMI), Thomas E Friel, Thomas J Arista, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiffani Wilson, Timothy T Kapsala, Tonia F Bernard, Travis R Hunt, Truong Xuan Nguyen (Andy), Ucheabuchi C Chudi Nwankwor, Uttaniti Limchumroon (Tom), Vesna V Stanoyevitch, Vlada Matusovsky, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, Wendy G Tan, PhD, Xikui Chen (nmi), PhD, Yong Hu, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Yvonne C Mcknight

Tiffani D Wilson's Documents

Publish Date Document Type Title
April, 2008 EIR AstraZeneca AB - EIR, 2018-05-08
December, 2014 EIR KVK-TECH, INC. - EIR, 2014-12-11
November, 2002 FDA 483 Response Charles River Laboratories, Inc. - Form 483R, 2002-12-19
December, 2011 FDA 483 Sigmapharm Laboratories, LLC - Form 483, 2011-12-22
November, 2002 FDA 483 Charles River Laboratories, Inc. - Form 483, 2002-11-25
December, 2014 FDA 483 KVK-TECH, INC. - Form 483, 2014-12-11
November, 2002 EIR Charles River Laboratories, Inc. - EIR, 2002-11-25
March, 2007 EIR Calumet Karns City Refining LLC - EIR, 2007-03-27
December, 2010 FDA 483 ARx, LLC - Form 483, 2010-12-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more